Universitätsklinikum Tübingen

Total Neoadjuvant Therapy as Organ Preserving Therapy for Rectal Cancer: The CAO/ARO/AIO-16 Phase II Study (2022) Gani C, Polat B, Ott O, Germer E, Koenigsrainer A, Kirschniak A, Clasen S, et al. Conference contribution Investigation of daily Activity, Sleep and neurocognitive Function in Glioblastoma Patients using TTFields Therapy in Routine clinical Care in Germany - the TIGER PRO-Active Study (2022) Glas M, Tabatabai G, Fietkau R, Goldbrunner R, Baehr O Conference contribution Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma (2022) Wendlinger S, Wohlfarth J, Kreft S, Siedel C, Kilian T, Dischinger U, Heppt M, et al. Journal article Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe (2022) Nowotny H, Neumann U, Tardy-Guidollet V, Faisal Ahmed S, Baronio F, Battelino T, Bertherat J, et al. Journal article Genetic characterization of advanced conjunctival melanoma and response to systemic treatment (2022) Lodde GC, Jansen P, Möller I, Sucker A, Hassel JC, Forschner A, Eckardt J, et al. Journal article Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference (2022) Kolberg-Liedtke C, Lueftner D, Brucker SY, Budach W, Denkert C, Fasching P, Haidinger R, et al. Journal article Early disruption of photoreceptor cell architecture and loss of vision in a humanized pig model of usher syndromes (2022) Grotz S, Schaefer J, Wunderlich KA, Ellederova Z, Auch H, Baehr A, Runa-Vochozkova P, et al. Journal article Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany (2022) Mohr P, Scherrer E, Assaf C, Bender M, Berking C, Chandwani S, Eigentler T, et al. Journal article MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients (2022) Hübner H, Häberle L, Müller V, Schrader I, Lorenz R, Forstbauer H, Fink V, et al. Journal article The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C (2022) De Gregorio A, Janni W, Friedl TWP, Nitz U, Rack B, Schneeweiss A, Kates R, et al. Journal article